SCHEMBL13985286

SCHEMBL13985286

C/C(=N\NNCN)c1ccc(NC(=O)Nc2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ TAAR1 Q96RJ0 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ KMT2A Q03164 6/20 0.50
▸ FAAH O00519 1/20 0.48
▸ MGLL Q99685 1/20 0.48
▸ MEN1 O00255 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ TP53 P04637 2/20 0.46
▸ EPHX1 P07099 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ EPHX2 P34913 1/20 0.46
▸ CDK9 P50750 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ SIRT1 Q96EB6 1/20 0.45
▸ CASP3 P42574 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13985285 0.80 PLK4 (0.57) KMT2AFAAHMGLLMEN1
SCHEMBL15849842 0.77 MAPT (0.56) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL31054222 0.76 NPC1 (0.69) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL1719786 0.72 RAB9A (1.00) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL13985114 0.72 MAPT (0.54) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL17453758 0.71 MAPT (0.68) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL15897789 0.71 BCHE (0.74) MAPTRAB9ANPC1KMT2AFAAH
SCHEMBL13985290 0.71 CA12 (0.56) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL13941428 0.70 FAAH (0.54) MAPTRAB9ANPC1TAAR1SMN1; SMN2
SCHEMBL11059378 0.70 SMN1; SMN2 (0.94) MAPTRAB9ANPC1TAAR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008156573-A1 KINASE INHIBITORS, COMPOSITIONS THEREOF, AND METHODS OF USE THEREWITH PROVID PHARMACEUTICALS, INC. (US) 2008-12-24 — — WO disclosed
Send feedback